CAL
TTOO

Capital Advisors Ltd’s T2 Biosystems, Inc TTOO Stock Holding History

Capital Advisors Ltd’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14
Closed -$1K – 1595
2023
Q1 		$1K Buy
+14
New +$1.53K ﹤0.01% 1159

Other funds holding TTOO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Advisors Ltd's TTOO Position: Q2 2023 in Review

Capital Advisors Ltd sold out of T2 Biosystems, Inc (TTOO) in Q2 2023, closing a stake of 14 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in TTOO in Q1 2023 and held it in 1 quarter. The position peaked at $1K in Q1 2023. 28 funds tracked by Wall St. Rank hold TTOO as of Q2 2023.

  • Capital Advisors Ltd reported no remaining T2 Biosystems, Inc position as of Q2 2023 after selling out during the quarter.
  • Capital Advisors Ltd sold 14 T2 Biosystems, Inc shares in Q2 2023, an estimated $1K.
  • Capital Advisors Ltd first reported a position in T2 Biosystems, Inc in Q1 2023 and held it in 1 quarter.
  • Capital Advisors Ltd's T2 Biosystems, Inc position peaked at $1K in Q1 2023.
  • 28 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2023.

Based on Capital Advisors Ltd's 13F filing for Q2 2023, filed 26 Jul 2023.